Citigroup’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.8M | Sell |
25,048
-10,729
| -30% | -$611K | ﹤0.01% | 2728 |
|
|
2025
Q4 | $1.51M | Buy |
35,777
+32,730
| +1,074% | +$1.83M | ﹤0.01% | 2839 |
|
|
2025
Q3 | $173K | Sell |
3,047
-3,890
| -56% | -$129K | ﹤0.01% | 4053 |
|
|
2025
Q2 | $179K | Sell |
6,937
-1,313
| -16% | -$14.7K | ﹤0.01% | 4123 |
|
|
2025
Q1 | $84.2K | Sell |
8,250
-926
| -10% | -$12.1K | ﹤0.01% | 4689 |
|
|
2024
Q4 | $128K | Buy |
9,176
+501
| +6% | +$8.84K | ﹤0.01% | 4700 |
|
|
2024
Q3 | $169K | Buy |
8,675
+5,998
| +224% | +$114K | ﹤0.01% | 4457 |
|
|
2024
Q2 | $49.8K | Buy |
2,677
+2,672
| +53,440% | +$56.3K | ﹤0.01% | 4579 |
|
|
2024
Q1 | $73 | Sell |
5
-23,843
| -100% | -$250K | ﹤0.01% | 5506 |
|
|
2023
Q4 | $202K | Buy |
23,848
+18,649
| +359% | +$141K | ﹤0.01% | 3917 |
|
|
2023
Q3 | $46.4K | Buy |
5,199
+4,951
| +1,996% | +$47.7K | ﹤0.01% | 4165 |
|
|
2023
Q2 | $2.14K | Sell |
248
-5,553
| -96% | -$59.2K | ﹤0.01% | 5281 |
|
|
2023
Q1 | $61.2K | Sell |
5,801
-2,839
| -33% | -$85.9K | ﹤0.01% | 4206 |
|
|
2022
Q4 | $293K | Sell |
8,640
-272
| -3% | -$13.2K | ﹤0.01% | 3525 |
|
|
2022
Q3 | $428K | Sell |
8,912
-2,914
| -25% | -$173K | ﹤0.01% | 3355 |
|
|
2022
Q2 | $674K | Sell |
11,826
-1,312
| -10% | -$82.8K | ﹤0.01% | 2996 |
|
|
2022
Q1 | $1.06M | Buy |
13,138
+5,159
| +65% | +$764K | ﹤0.01% | 2905 |
|
|
2021
Q4 | $1.62M | Buy |
7,979
+3,900
| +96% | +$846K | ﹤0.01% | 2796 |
|
|
2021
Q3 | $1.1M | Sell |
4,079
-2,020
| -33% | -$486K | ﹤0.01% | 3012 |
|
|
2021
Q2 | $1.57M | Buy |
6,099
+1,724
| +39% | +$477K | ﹤0.01% | 2863 |
|
|
2021
Q1 | $1.31M | Sell |
4,375
-3,145
| -42% | -$979K | ﹤0.01% | 2780 |
|
|
2020
Q4 | $1.92M | Sell |
7,520
-501
| -6% | -$129K | ﹤0.01% | 2898 |
|
|
2020
Q3 | $2M | Sell |
8,021
-2,054
| -20% | -$646K | ﹤0.01% | 2649 |
|
|
2020
Q2 | $3.5M | Sell |
10,075
-928
| -8% | -$290K | ﹤0.01% | 2207 |
|
|
2020
Q1 | $2.95M | Buy |
11,003
+4,375
| +66% | +$1.35M | ﹤0.01% | 2121 |
|
|
2019
Q4 | $2.15M | Sell |
6,628
-5,621
| -46% | -$1.63M | ﹤0.01% | 2891 |
|
|
2019
Q3 | $3.35M | Buy |
12,249
+6,629
| +118% | +$2.43M | ﹤0.01% | 2316 |
|
|
2019
Q2 | $3M | Sell |
5,620
-1,687
| -23% | -$846K | ﹤0.01% | 2401 |
|
|
2019
Q1 | $3.68M | Sell |
7,307
-1,584
| -18% | -$939K | ﹤0.01% | 2053 |
|
|
2018
Q4 | $4.38M | Buy |
8,891
+2,910
| +49% | +$1.76M | ﹤0.01% | 1925 |
|
|
2018
Q3 | $5.47M | Buy |
5,981
+5,664
| +1,787% | +$4.83M | ﹤0.01% | 1775 |
|
|
2018
Q2 | $232K | Sell |
317
-2,116
| -87% | -$2.44M | ﹤0.01% | 4904 |
|
|
2018
Q1 | $3.88M | Buy |
2,433
+2,316
| +1,979% | +$2.98M | ﹤0.01% | 2001 |
|
|
2017
Q4 | $105K | Sell |
117
-7,745
| -99% | -$4.58M | ﹤0.01% | 5597 |
|
|
2017
Q3 | $2.83M | Sell |
7,862
-5,691
| -42% | -$1.78M | ﹤0.01% | 2297 |
|
|
2017
Q2 | $3.98M | Buy |
13,553
+569
| +4% | +$164K | ﹤0.01% | 1905 |
|
|
2017
Q1 | $4.57M | Sell |
12,984
-5,840
| -31% | -$1.31M | ﹤0.01% | 1742 |
|
|
2016
Q4 | $3.46M | Buy |
18,824
+11,562
| +159% | +$2.35M | ﹤0.01% | 2271 |
|
|
2016
Q3 | $1.87M | Buy |
7,262
+2,643
| +57% | +$681K | ﹤0.01% | 2576 |
|
|
2016
Q2 | $985K | Sell |
4,619
-1,857
| -29% | -$415K | ﹤0.01% | 2982 |
|
|
2016
Q1 | $1.34M | Buy |
6,476
+5,983
| +1,214% | +$1.15M | ﹤0.01% | 2983 |
|
|
2015
Q4 | $125K | Sell |
493
-2,245
| -82% | -$462K | ﹤0.01% | 5171 |
|
|
2015
Q3 | $450K | Buy |
2,738
+1,980
| +261% | +$350K | ﹤0.01% | 3838 |
|
|
2015
Q2 | $141K | Sell |
758
-1,195
| -61% | -$206K | ﹤0.01% | 4733 |
|
|
2015
Q1 | $322K | Sell |
1,953
-1,262
| -39% | -$259K | ﹤0.01% | 4125 |
|
|
2014
Q4 | $747K | Buy |
3,215
+2,882
| +865% | +$616K | ﹤0.01% | 3441 |
|
|
2014
Q3 | $60K | Buy |
333
+168
| +102% | +$32.1K | ﹤0.01% | 5170 |
|
|
2014
Q2 | $33K | Sell |
165
-1,674
| -91% | -$296K | ﹤0.01% | 5460 |
|
|
2014
Q1 | $335K | Sell |
1,839
-1,354
| -42% | -$268K | ﹤0.01% | 3852 |
|
|
2013
Q4 | $544K | Buy |
3,193
+1,066
| +50% | +$172K | ﹤0.01% | 3722 |
|
|
2013
Q3 | $333K | Buy |
2,127
+1,009
| +90% | +$187K | ﹤0.01% | 3765 |
|
|
2013
Q2 | $193K | Buy |
+1,118
| New | +$171K | ﹤0.01% | 4300 |
|
Other funds holding NKTR
BI
TSC
VCM
PM
AC
Citigroup's NKTR Position: Q1 2026 in Review
Citigroup reduced its Nektar Therapeutics (NKTR) stake by 30% in Q1 2026, selling an estimated $611K and leaving 25,048 shares worth $1.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2728.
Citigroup first reported a position in NKTR in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.47M in Q3 2018. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.
- Citigroup held 25,048 shares of Nektar Therapeutics worth $1.8M as of Q1 2026.
- Citigroup sold 10,729 Nektar Therapeutics shares in Q1 2026, an estimated $611K.
- Nektar Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2728 holding.
- Citigroup first reported a position in Nektar Therapeutics in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Nektar Therapeutics position peaked at $5.47M in Q3 2018.
- 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.